Synopsis:
Tatva Chintan Pharma Chem surged over 14 percent today after Mukul Agarwal bought a 1.28 percent stake in the business.
The shares of this leading specialty chemical manufacturer surged over 14 percent after ace investor Mukul Agarwal bought a fresh stake in the business. In this article, we will dive into the details.
With a market capitalization of Rs 2,411 crores, the shares of Tatva Chintan Pharma Chem are currently trading at Rs 1,030 per share, down by 12 percent from its 52-week high of Rs 1,174.15 per share. Post its listing on July 29, 2021, the stock has corrected by over 54 percent.
According to the latest shareholding data disclosed by the company, ace investor Mukul Agarwal has newly acquired a 1.28 percent stake, which translates to 3,00,000 equity shares.
His entry into the company signals growing interest from seasoned investors in the firm’s future potential. As per the latest corporate shareholdings filed, Mukul Agrawal publicly holds 62 stocks with a net worth of over Rs. 7,578 crore.
In addition, Goldman Sachs also holds a 2.59 percent stake, amounting to 6,06,662 shares in the company. The presence of such prominent institutional investors adds credibility and reflects strong institutional confidence in the business outlook.
Financial Highlights
Tatva Chinta reported a revenue decline of 2.8 percent to Rs 383 crores in FY25 from Rs 394 crores in FY24. Additionally, its net profit declined by 80 percent to Rs 6 crores in FY25 from Rs 30 crores in FY24.
The stock delivered a poor ROE and ROCE of 0.77 percent and 1.16 percent, respectively, and is currently trading at a high P/E of 422.17x as compared to its industry average of 34.89x.
Tatva Chintan Pharma Chem Limited is an Indian company that specializes in producing and selling specialty chemicals, both domestically and internationally. Their diverse product lineup features chemicals essential for creating zeolites, phase transfer catalysts, salts for supercapacitors and zinc-ion batteries, as well as a variety of offerings for the pharmaceutical and agrochemical industries.
Additionally, the company manufactures specialty chemicals such as intermediates, disinfectants, catalysts, and solvents. Their clientele spans multiple sectors, including automotive, refineries, pharmaceuticals, agrochemicals, paints and coatings, dyes and pigments, personal care, and fragrances.
Written by Satyajeet Mukherjee
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
